We report here that CD8+ and CD4+ T cells in PB as well as in BM of AML patients at relapse after allo-SCT showed increased expression of PD-1, in contrast to T cells of AML patients at diagnosis. This evidence concerns the gene CD4 and acute myeloid leukemia.